Jiangsu Chenpai Bond Pharmaceutical

Jiangsu Chenpai Bond Pharmaceutical is a Chinese pharmaceutical company specializing in the research, development, and large-scale manufacturing of finished dosage forms and active pharmaceutical ingredients (APIs). The company operates high-standard production facilities, including dedicated workshops for hormones and psychotropic drugs, and maintains a strong focus on gastrointestinal and psychiatric health. Its product portfolio includes widely used treatments such as Rabeprazole Sodium for gastric acid disorders and Sulpiride for mental health conditions. Chenpai Bond is recognized for its integrated approach to drug production, ensuring quality control from raw material synthesis to final packaging for both domestic and international markets.